FOXO4 2mg × 10
Research-use disclaimer
All products are strictly for laboratory research and in-vitro studies, not for human consumption.
Description
FOXO4-DRI is a synthetic senolytic peptide designed to selectively eliminate senescent (“aging”) cells by disrupting the interaction between FOXO4 and p53, triggering apoptosis in dysfunctional cells while preserving healthy tissue. Research suggests FOXO4-DRI may help reduce age-related inflammation, improve tissue function, support cellular rejuvenation, and enhance healthy aging processes. Preclinical studies have shown potential benefits in restoring physical function, improving organ health, and reducing markers associated with cellular senescence. FOXO4-DRI is widely studied in longevity, regenerative medicine, and anti-aging research focused on senescent cell clearance and tissue renewal. This content is for research and informational purposes only and should not be interpreted as medical advice.
Product research FAQ
What is this product intended for?
It is supplied strictly for laboratory research and in-vitro studies, not for human consumption.
Is batch documentation available?
Available batch-specific Certificates of Analysis are listed in the COA section on this page.
How should the product be stored?
Follow the storage information shown on this page and the instructions supplied with the specific batch.
